リボソームタンパク質S6キナーゼ1シグナリングは,哺乳類の寿命を調節する
Colin Selman1, Jennifer M A Tullet, Daniela Wieser
1Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK.
まとめ
マウスのリボソームS6タンパク質キナーゼ1 (S6K1) を削除することで,カロリー制限の効果を模倣し,寿命を延ばし,健康状態を改善しました. これは,S6K1とAMPKの操作が,老化疾患に対する保護を提供することを示唆しています.
科学分野:
- 老化に関する研究.
- 分子生物学は分子生物学である.
- メタボリック経路は
背景:
- カロリー制限 (CR) は,哺乳類の寿命を延ばし,年齢関連の疾患から保護することが知られている.
- CRの利点,特に栄養素感知経路への影響の基礎となる正確な分子機構は,まだ完全に理解されていません.
研究 の 目的:
- リボソームS6タンパク質キナーゼ1 (S6K1) の老化および年齢関連の病理における役割を調査する.
- S6K1を操作することで,カロリー制限の有益な効果を複製できるかどうかを調べる.
主な方法:
- S6K1 削除された遺伝子組み換えマウスを利用しました.
- 分析された寿命,年齢関連の病理 (骨,免疫,運動機能,インスリン感受性),および遺伝子発現パターン.
- 遺伝子発現プロフィールを,カロリー制限とAMPK活性化によって誘発されたプロフィールと比較した.
主要な成果:
- マウスのS6K1のデリエーションにより,寿命が著しく増加しました.
- S6K1が欠けていたマウスは,骨,免疫,運動の欠陥を含む複数の年齢関連の機能障害に対する耐性を示し,インスリン感受性の向上を示した.
- S6K1が削除されたマウスの遺伝子発現の変化は,カロリー制限およびアデノシンモノフォスファート (AMP) 活性化タンパク質キナーゼ (AMPK) 活性化で観察されたパターンを反映しています.
結論:
- リボソームS6タンパク質キナーゼ1 (S6K1) は,哺乳類の健康な寿命の調節に重要な役割を果たしています.
- S6K1とAMPK経路の治療的ターゲティングは,カロリー制限の利点を模倣する戦略を提供することができる.
- このような介入は,老化による様々な病気に対する広範な保護の可能性を秘めています.
関連する概念動画
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Translational Regulation
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...


